Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard W Price

Showing results (41-50 of 148) with videos related to

Pageof 15
Sort By:
Plos One|September 2, 2009
Raltegravir cerebrospinal fluid concentrations in HIV-1 infectionAylin Yilmaz, Magnus Gisslén, Serena Spudich, et al.
Journal of Neuroimmunology|August 11, 2005
Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infectionPaola Cinque, Arabella Bestetti, Roberta Marenzi, et al.
Antiviral Therapy|October 13, 2005
Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatmentAsa Mellgren, Andrea Antinori, Paola Cinque, et al.
AIDS Research and Therapy|May 17, 2011
Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot studyEmily L Ho, Serena S Spudich, Evelyn Lee, et al.
Current HIV/AIDS Reports|January 17, 2019
Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological DisordersAylin Yilmaz, Dietmar Fuchs, Richard W Price, et al.
Plos Pathogens|March 27, 2015
Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infectionChrista Buckheit Sturdevant, Sarah B Joseph, Gretja Schnell, et al.
AIDS (London, England)|December 6, 2012
Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllersViktor Dahl, Julia Peterson, Serena Spudich, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkersMagnus Gisslen, Lars Hagberg, Lars Rosengren, et al.
Journal of the Neurological Sciences|June 10, 2011
Training needs and evaluation of a neuro-HIV training module for non-physician healthcare workers in western KenyaDeanna Cettomai, Judith Kwasa, Gretchen L Birbeck, et al.
AIDS Research and Human Retroviruses|March 27, 2009
Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individualsAylin Yilmaz, Arash Izadkhashti, Richard W Price, et al.
Pageof 15

Showing results (41-50 of 148) with videos related to

Sort By:
Pageof 15
Plos One|September 2, 2009
Raltegravir cerebrospinal fluid concentrations in HIV-1 infectionAylin Yilmaz, Magnus Gisslén, Serena Spudich, et al.
Journal of Neuroimmunology|August 11, 2005
Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infectionPaola Cinque, Arabella Bestetti, Roberta Marenzi, et al.
Antiviral Therapy|October 13, 2005
Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatmentAsa Mellgren, Andrea Antinori, Paola Cinque, et al.
AIDS Research and Therapy|May 17, 2011
Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot studyEmily L Ho, Serena S Spudich, Evelyn Lee, et al.
Current HIV/AIDS Reports|January 17, 2019
Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological DisordersAylin Yilmaz, Dietmar Fuchs, Richard W Price, et al.
Plos Pathogens|March 27, 2015
Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infectionChrista Buckheit Sturdevant, Sarah B Joseph, Gretja Schnell, et al.
AIDS (London, England)|December 6, 2012
Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllersViktor Dahl, Julia Peterson, Serena Spudich, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkersMagnus Gisslen, Lars Hagberg, Lars Rosengren, et al.
Journal of the Neurological Sciences|June 10, 2011
Training needs and evaluation of a neuro-HIV training module for non-physician healthcare workers in western KenyaDeanna Cettomai, Judith Kwasa, Gretchen L Birbeck, et al.
AIDS Research and Human Retroviruses|March 27, 2009
Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individualsAylin Yilmaz, Arash Izadkhashti, Richard W Price, et al.
Pageof 15